Records containing: Neuroblastoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-05-06Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2021-02-21High-dose MIBG With Subsequent Transplantation of Haploidentical Stem Cells in Children With Therapy Resistant Neuroblastoma
-
CLINICAL_TRIALS study record update · 2021-02-02Safety & Efficacy of 68Ga-DOTA-tyr3-Octreotide PET/CT in Diagnosis, Staging & Measurement of Response to Treatment in Patients With Somatostatin Receptor Positive Tumors: Comparison to Octreoscan Plus High-Resolution, Contrast Enhanced CT.
-
CLINICAL_TRIALS study record update · 2021-01-26A Sub-study of 18F-DCFPyL Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of Recurrent Prostate Cancer Evaluation of the Safety and Sensitivity of 68Ga-DOTATOC PET/CT for Imaging NET Patients
-
CLINICAL_TRIALS study record update · 2021-01-22Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-21Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2020-11-19Multi-center Phase I/II Clinical Trial of 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
-
CLINICAL_TRIALS study record update · 2020-11-05Characterization of Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
-
CLINICAL_TRIALS study record update · 2020-10-29Prospective and Randomized Study of Fixed Versus Flexible Prophylactic Administration of Granulocyte Colony-Stimulating Factor (G-CSF) in Children With Cancer
-
CLINICAL_TRIALS study record update · 2020-10-23High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN)
-
CLINICAL_TRIALS study record update · 2020-10-22Bridging Study Using ch14.18/CHO Antibody in Children With Refractory Neuroblastoma
-
CLINICAL_TRIALS study record update · 2020-10-08Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI), Pediatric Oncology Branch (POB) Clinical Research Protocols
-
CLINICAL_TRIALS study record update · 2020-09-21A Pilot Study of Imetelstat Given Intravenously on Day 1 and 8 of a 21 Day Schedule Alone and With Standard 13-Cis-Retinoic Acid in Children With Recurrent and/or Refractory Neuroblastoma
-
CLINICAL_TRIALS study record update · 2020-07-14A Phase I/II Dose Schedule Finding Study of ch14.18/CHO Continuous Infusion Combined With Subcutaneous Aldesleukin (IL-2) in Patients With Primary Refractory or Relapsed Neuroblastoma
-
CLINICAL_TRIALS study record update · 2020-05-29Sirolimus in Combination With Metronomic Therapy in Children With Recurrent and Refractory Solid Tumors: A Phase I Study
-
CLINICAL_TRIALS study record update · 2020-04-03A Phase II Preventative Trial of DFMO (Eflornithine HCl) as a Single Agent in Patients With High Risk Neuroblastoma in Remission
-
CLINICAL_TRIALS study record update · 2020-04-03A Phase 1 Study Using Simvastatin in Combination With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
-
CLINICAL_TRIALS study record update · 2020-03-12A Safety Pilot Study of High Risk Induction Chemotherapy for Neuroblastoma Without Prophylactic Administration of Myeloid Growth Factors
-
CLINICAL_TRIALS study record update · 2020-02-28Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma
-
CLINICAL_TRIALS study record update · 2020-02-25Investigating the Microbiome and Volatile Organic Compound Profile of Children With Neuroblastoma - a Pilot Study
-
CLINICAL_TRIALS study record update · 2020-02-17TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT/REFRACTORY SOLID TUMORS WITH HIGH DOSE ETOPOSIDE AND CARBOPLATIN PLUS ESCALATING DOSE CYCLOPHOSPHAMIDE, FOLLOWED BY HEMATOPOIETIC RESCUE USING AUTOLOGOUS CD34+ SELECTED BLOOD STEM CELLS: A PILOT STUDY
-
CLINICAL_TRIALS study record update · 2020-01-18Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo(Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Children and Adolescents With Refractory Cancer
-
CLINICAL_TRIALS study record update · 2019-12-17A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) With or Without Interferon Gamma in Patients With Refractory Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-12-17A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults With Treatment Refractory Cancer
-
CLINICAL_TRIALS study record update · 2019-11-15Regulatory T Cells at Engraftment as Predictors of Acute Graft-Versus-Host Disease Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation